ChemicalBook > Product Catalog >Biochemical Engineering >Inhibitors >Epigenetics >DNA Methyltransferase Inhibitors >SGI-1027

SGI-1027

SGI-1027 Structure
CAS No.
1020149-73-8
Chemical Name:
SGI-1027
Synonyms
CS-1144;SGI-1027;SGI1027; SGI 1027;SGI-1027 USP/EP/BP;DNA Methyltransferase Inhibitor II;N-[4-[(2-Amino-6-methyl-4-pyrimidinyl)amino]phenyl]-4-(4-quinolinylamino)benzamide;N-[4-[(2-amino-6-methylpyrimidin-4-yl)amino]phenyl]-4-(quinolin-4-ylamino)benzamide;Benzamide, N-[4-[(2-amino-6-methyl-4-pyrimidinyl)amino]phenyl]-4-(4-quinolinylamino)-;N-[4-[(2-Amino-6-methyl-4-pyrimidinyl)amino]phenyl]-4-(4-quinolinylamino)benzamide SGI-1027;SGI-1027 N-[4-[(2-Amino-6-methyl-4-pyrimidinyl)amino]phenyl]-4-(4-quinolinylamino)benzamide
CBNumber:
CB42663344
Molecular Formula:
C27H23N7O
Molecular Weight:
461.52
MOL File:
1020149-73-8.mol
MSDS File:
SDS
Modify Date:
2023/6/30 15:45:59

SGI-1027 Properties

Melting point >280℃
Density 1.387±0.06 g/cm3(Predicted)
storage temp. 2-8°C
solubility Soluble in DMSO (up to 35 mg/ml)
pka 13.31±0.70(Predicted)
form powder
color white to light brown
Stability Stable for 2 years as supplied. Solutions in DMSO may be stored at -20°C for up to 3 months.

SGI-1027 price More Price(2)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Sigma-Aldrich(India) SML1358 SGI-1027 ≥98% (HPLC) 1020149-73-8 5MG ₹13908.3 2022-06-14 Buy
Sigma-Aldrich(India) SML1358 SGI-1027 ≥98% (HPLC) 1020149-73-8 25MG ₹55932.9 2022-06-14 Buy
Product number Packaging Price Buy
SML1358 5MG ₹13908.3 Buy
SML1358 25MG ₹55932.9 Buy

SGI-1027 Chemical Properties,Uses,Production

Uses

SGI-1027 is a quinoline derivative and a potent inhibitor of DNA methyltransferase (DNMT). SGI-1027 can be used as a potential therapeutic agent for the treatment of cancer and other diseases and also as a research tool to investigate the role of DNMTs in epigenetic events.

Biochem/physiol Actions

SGI-1027 is a DNA methyltransferase (DNMT) inhibitor with IC50 values of 6-13 μM for DNMT3B, DNMT3A and DNMT1. SGI-1027 directly inhibits DNMT activity by competing with the cofactor, S-adenosylmethionine (SAM) in the methylation reaction. SGI-1027 treatment of cancer cell lines induced degradation of DNMT1, but not DNMT3A or DNMT3B, and in RKO cells caused re-expression of the silenced tumor supressor genes p16, MLH1 and TIMP3.

Global( 88)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
A.J Chemicals 91-9810153283 New Delhi, India 6124 58 Inquiry
CLEARSYNTH LABS LTD. +91-22-45045900 Hyderabad, India 6351 58 Inquiry
ATK CHEMICAL COMPANY LIMITED +undefined-21-51877795 China 32760 60 Inquiry
TargetMol Chemicals Inc. +1-781-999-5354 +1-00000000000 United States 19892 58 Inquiry
Career Henan Chemica Co +86-0371-86658258 +8613203830695 China 30253 58 Inquiry
Dideu Industries Group Limited +86-29-89586680 +86-15129568250 China 26216 58 Inquiry
Zhejiang J&C Biological Technology Co.,Limited +1-2135480471 +1-2135480471 China 10522 58 Inquiry
InvivoChem +1-708-310-1919 +1-13798911105 United States 6393 58 Inquiry
Coresyn Pharmatech Co., Ltd. +86-571-86626709 +86-18157142896 China 9991 58 Inquiry
ShenZhen Trendseen Biological Technology Co.,Ltd. 13417589054 China 11681 58 Inquiry

SGI-1027 Spectrum

N-[4-[(2-amino-6-methylpyrimidin-4-yl)amino]phenyl]-4-(quinolin-4-ylamino)benzamide SGI-1027 N-[4-[(2-Amino-6-methyl-4-pyrimidinyl)amino]phenyl]-4-(4-quinolinylamino)benzamide DNA Methyltransferase Inhibitor II Benzamide, N-[4-[(2-amino-6-methyl-4-pyrimidinyl)amino]phenyl]-4-(4-quinolinylamino)- N-[4-[(2-Amino-6-methyl-4-pyrimidinyl)amino]phenyl]-4-(4-quinolinylamino)benzamide SGI-1027 SGI-1027 N-[4-[(2-Amino-6-methyl-4-pyrimidinyl)amino]phenyl]-4-(4-quinolinylamino)benzamide CS-1144 SGI1027; SGI 1027 SGI-1027 USP/EP/BP 1020149-73-8 C27H23N7O Inhibitors